Geron Corp (NASDAQ:GERN)
| 1.46 Delayed Data As of 3:59pm ET |  +0.005 / +0.34%Today’s Change | 1.20 Today|||52-Week Range 2.36 | -8.49% Year-to-Date |
Latest GERN News | Press Releases
No recent news for Geron Corp.
Today’s Trading
| Previous close | 1.45 |
| Today’s open | 1.44 |
| Day’s range | 1.43 - 1.46 |
| Volume | 22,360 |
| Average volume (3 months) | 6,460,386 |
| Market cap | $456.9M |
Data as of 3:59pm ET, 10/20/2021
Growth & Valuation
| Earnings growth (last year) | +22.72% |
| Earnings growth (this year) | -26.43% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -45.00% |
| P/E ratio | NM |
| Price/Sales | 1,706.02 |
| Price/Book | 2.10 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SELBSelecta Biosciences ... | -0.19 | -4.66% |
| EPZMEpizyme Inc | +0.07 | +1.56% |
| XXII22nd Century Group I... | +0.03 | +1.03% |
| VTGNVistaGen Therapeutic... | 0.00 | 0.00% |
Data as of 3:59pm ET, 10/20/2021
Financials
| Next reporting date | November 4, 2021 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $253.0K |
| Annual profit (last year) | -$75.6M |
| Net profit margin | -29,888.14% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
